SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DEGLI UBERTI, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.185
AS - Asia 18.708
EU - Europa 16.788
SA - Sud America 2.931
AF - Africa 398
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 21
Totale 73.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.426
SG - Singapore 6.941
FI - Finlandia 6.374
CN - Cina 4.947
DE - Germania 3.130
BR - Brasile 2.314
UA - Ucraina 2.017
VN - Vietnam 1.926
HK - Hong Kong 1.479
IT - Italia 1.464
TR - Turchia 1.238
GB - Regno Unito 1.029
RU - Federazione Russa 760
FR - Francia 622
SE - Svezia 540
BD - Bangladesh 523
JP - Giappone 424
IN - India 361
CA - Canada 338
MX - Messico 293
PL - Polonia 276
AR - Argentina 216
ZA - Sudafrica 163
ID - Indonesia 121
IQ - Iraq 118
PK - Pakistan 108
ES - Italia 103
EC - Ecuador 99
NL - Olanda 97
CO - Colombia 79
BE - Belgio 77
VE - Venezuela 74
UZ - Uzbekistan 63
MA - Marocco 54
SA - Arabia Saudita 53
CL - Cile 51
PH - Filippine 51
MY - Malesia 48
LT - Lituania 46
AT - Austria 38
TN - Tunisia 37
AE - Emirati Arabi Uniti 34
PY - Paraguay 33
KE - Kenya 31
AU - Australia 27
IR - Iran 27
PE - Perù 26
DZ - Algeria 25
IE - Irlanda 24
JM - Giamaica 24
JO - Giordania 24
NP - Nepal 24
AL - Albania 22
EG - Egitto 21
UY - Uruguay 20
PS - Palestinian Territory 19
AZ - Azerbaigian 18
CH - Svizzera 18
LB - Libano 18
RO - Romania 18
CZ - Repubblica Ceca 17
DK - Danimarca 16
DO - Repubblica Dominicana 16
KZ - Kazakistan 16
BO - Bolivia 15
EU - Europa 14
IL - Israele 14
OM - Oman 14
TH - Thailandia 13
TT - Trinidad e Tobago 13
CR - Costa Rica 12
ET - Etiopia 12
GR - Grecia 12
HN - Honduras 12
PT - Portogallo 12
KR - Corea 11
LV - Lettonia 10
MD - Moldavia 10
PA - Panama 10
BG - Bulgaria 9
GA - Gabon 9
KG - Kirghizistan 9
RS - Serbia 9
CY - Cipro 8
GT - Guatemala 8
QA - Qatar 8
SV - El Salvador 8
BB - Barbados 7
BH - Bahrain 7
GE - Georgia 7
HU - Ungheria 7
AM - Armenia 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AO - Angola 5
HR - Croazia 5
KW - Kuwait 5
MT - Malta 5
NI - Nicaragua 5
Totale 72.965
Salva come PNG Salva come JPEG
Città #
Helsinki 5.836
Singapore 4.530
Ashburn 3.802
Woodbridge 3.027
Fairfield 2.449
San Jose 2.284
Jacksonville 2.169
Chandler 2.078
Houston 1.774
Beijing 1.527
Santa Clara 1.488
Hong Kong 1.460
Ann Arbor 1.271
Seattle 975
Wilmington 952
Cambridge 747
Izmir 680
Ho Chi Minh City 650
Nanjing 620
Los Angeles 565
New York 521
Dallas 467
Hanoi 445
Princeton 440
Tokyo 412
Munich 399
Addison 384
Lauterbourg 358
San Diego 280
Boardman 269
Milan 262
Warsaw 260
São Paulo 256
Shanghai 210
Shenyang 198
Mexico City 196
Nanchang 181
Orem 173
Council Bluffs 168
Dearborn 163
Ferrara 138
Turku 137
Hebei 134
Tianjin 133
Buffalo 132
Hefei 128
Washington 121
London 118
Changsha 117
Montreal 113
Bremen 110
Chicago 105
Brooklyn 102
Denver 97
Jiaxing 97
Chennai 96
Johannesburg 93
Toronto 89
Jinan 84
Haiphong 83
Da Nang 82
San Francisco 81
Boston 73
Phoenix 72
Frankfurt am Main 70
Falls Church 69
Brussels 68
Moscow 68
Atlanta 67
Mountain View 67
Rome 66
Stockholm 66
Poplar 64
San Mateo 63
Manchester 62
Rio de Janeiro 62
Belo Horizonte 60
Baghdad 54
The Dalles 54
Guangzhou 53
Tashkent 53
Norwalk 52
Hải Dương 51
Kunming 49
Zhengzhou 48
Falkenstein 45
Ningbo 45
Redwood City 45
Amsterdam 43
Ankara 40
Biên Hòa 40
Carrara 40
Nuremberg 39
Lahore 38
Quito 38
Brasília 37
Jakarta 37
Auburn Hills 36
Charlotte 36
Philadelphia 36
Totale 49.322
Salva come PNG Salva come JPEG
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.985
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.960
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.958
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 434
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 326
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 288
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 281
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 279
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 276
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 275
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 267
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 266
Igf-I influences everolimus activity in medullary thyroid carcinoma 263
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 260
Evaluation of ''ROLL-like'' procedure for minimallyinvasive radioguided parathyroidectomy (MIRP) in hyperparathyroidism (HPT). 258
Characterization of a deleted Y chromosome in a male with Turner stigmata 257
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 256
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 253
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 247
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 247
Circadian profile of plasma calcitonin gene-related peptide in healthy man 246
A practical method for the estimation of therapeutic activity in the treatment of Graves' hyperthyroidism 244
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 243
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 243
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 241
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 240
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 239
A c-myc gene variant without exon 1 and with an abnormal methylation pattern inherited in a woman with no evidence of malignancy 238
The effects of dermorphin on the endocrine system in man 238
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 237
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 236
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 235
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 234
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 232
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 232
Dermorphin inhibits spinal nociceptive flexion reflex in humans 231
Functional characterization of a new deletion in CDKN1B 5'-UTR region 231
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 229
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 228
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 227
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 225
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 224
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 224
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 223
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 223
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 222
c-myc oncogene alterations in human thyroid carcinomas. 222
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 221
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 220
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 220
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 219
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 219
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 219
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 217
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 216
Growth hormone excess promotes breast cancer chemoresistance 215
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 214
Growth hormone induces chemoresistance in breast cancer cells 214
Evidence for androgen receptor gene expression in human thyroid cells and tumours 214
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 213
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 213
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 213
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 212
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 211
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 210
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 207
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 207
Circadian variations of plasma TSH in patients with severe hypothyroidism 206
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 205
miR-15a and miR-16-1 down-regulation in pituitary adenomas 205
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 205
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 204
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 203
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 203
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 203
Antiproliferative effects of somatostatin analogs in pituitary adenomas 202
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 202
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 202
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 202
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 202
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 201
Diurnal rhythm of plasma catecholamines in acromegaly 200
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 199
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 199
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 198
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 198
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 197
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 196
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 196
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 196
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
L’iperplasia surrenale congenita e la pubertà precoce 196
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 194
A new VHL polymorphism in a big family from Ferrara 194
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 193
Totale 27.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 294.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 19.434
Totale 313.830
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.080 129 416 246 180 192 186 164 183 164 338 437 1.445
2022/20234.399 443 303 175 595 687 658 179 383 578 32 214 152
2023/20242.338 200 274 132 62 204 382 71 462 40 28 34 449
2024/20258.348 230 180 625 210 1.067 876 307 351 1.297 985 1.247 973
2025/202630.251 2.330 980 2.087 3.099 3.895 1.660 2.894 1.202 7.887 2.615 998 604
2026/2027505 505 0 0 0 0 0 0 0 0 0 0 0
Totale 73.373